# Peptides Emporium — Skin & Aesthetics Research Peptides > Peptides Emporium is a reference digest for Skin & Aesthetics research peptides — Melanotan II and GHK-Cu — summarized from peer-reviewed literature. A literature desk, not a vendor or clinic. A literature desk covering the published research on Melanotan II (melanocortin agonism, pigmentation) and GHK-Cu (copper-mediated collagen signaling) — what each was actually studied for, in which species, and how far the evidence reaches. ## The short version Peptides Emporium is a reading desk, not a store. It collects what the published research literature actually says about two peptides studied in the context of **skin biology and aesthetics**: Melanotan II and GHK-Cu. A *peptide* is a short chain of amino acids — the same building blocks as proteins, only smaller. Each of these has been studied because it appears to act on a specific part of skin cell biology: one drives the pigment machinery that tans skin, the other coaxes fibroblasts to rebuild the collagen scaffold underneath it. This desk does one job: it tells you, in plain language and with citations, what each peptide was tested on, in which species, and how solid that evidence actually is. Most of it is preclinical. Melanotan II has no regulatory approval anywhere and carries documented safety risks. GHK-Cu is a legal cosmetic ingredient in topical form, but systemic use is unapproved and research-only. Neither is a medicine. This site does not sell anything and never lists a human dose. ## What are research peptides? A *research peptide* is a short amino-acid chain that has been synthesized and studied in laboratories — in cell cultures, in animals, and occasionally in early human pilots — but has **not** been approved by a regulator as a medicine. Sellers describe these compounds as being for laboratory use only, and that framing is not fine print: it signals that dosing, long-term safety, and real-world efficacy in people are usually unknown or incompletely characterized. When this desk reports a number, it reports it as the study did — for example, *studied at 0.025 mg/kg in men with psychogenic erectile dysfunction* — never as a recommendation. Where a peptide is derived from a natural molecule (like a hormone or structural protein), we say so, because lineage is often the key to mechanism. What the body already uses tells you where the signal points; it does not tell you that using more of it is safe or effective. ## How these two fit into skin research The two peptides on this desk approach skin biology from opposite ends. - [**Melanotan II**](/melanotan-2) is the lead. It is a cyclic analog of alpha-melanocyte-stimulating hormone (alpha-MSH) that activates the MC1R receptor on melanocytes, driving the cAMP-PKA-MITF cascade that turns on tyrosinase and shifts pigment production toward the darker eumelanin form — producing skin darkening without requiring UV [4][6]. It also activates MC4R and MC3R, which is why appetite suppression and erection are both documented effects. Two small Phase I studies constitute the only controlled human data; no Phase II or Phase III trial has been completed [4][6]. It is not FDA-approved, has no approval from any regulator, and is prohibited in sport under WADA's S0 category. - [**GHK-Cu**](/ghk-cu) approaches the skin from the connective tissue upward. It is a tiny copper-binding tripeptide that signals dermal fibroblasts to synthesize collagen, elastin and glycosaminoglycans, while its copper ion enables the cross-linking that holds that matrix together [11]. Of the two, GHK-Cu has the most human evidence — but that evidence is overwhelmingly *topical* (applied to skin surfaces) and limited to small trials [8]. Together they sketch the pigmentation-versus-matrix dimension of skin research. Use the card above to read each compound, or [compare these peptides](/compare) side by side. ## A note on how this desk reads the literature Peptides Emporium is a cross-referenced literature digest. Each peptide page summarizes the peer-reviewed studies for that compound, cites them by number, and links to a single shared [references list](/references) that collects every source. Where the evidence is thin, preclinical, or restricted to a specific route of administration, we say so plainly — that honesty is the purpose of the desk, not a caveat appended at the end. We describe research findings and the cited cautions that attach to them. We do not recommend, prescribe, or sell. --- Peer-reviewed literature on two skin peptides. Not a clinic, not a vendor, not a dose.